Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:1087-1094

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jousilahti, P.
Right arrow Articles by Puska, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jousilahti, P.
Right arrow Articles by Puska, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL

(Circulation. 1998;97:1087-1094.)
© 1998 American Heart Association, Inc.


Current Perspectives

Serum Cholesterol Distribution and Coronary Heart Disease Risk

Observations and Predictions Among Middle-aged Population in Eastern Finland

Pekka Jousilahti, MD; Erkki Vartiainen, MD; Juha Pekkanen, MD; Jaakko Tuomilehto, MD; Jouko Sundvall, MSc; ; Pekka Puska, MD

From the National Public Health Institute, Department of Epidemiology and Health Promotion (P.J., E.V., J.T., P.P.), Helsinki, Finland; National Public Health Institute, Unit of Environmental Epidemiology (J.P.), Kuopio, Finland; and National Public Health Institute, Department of Biochemistry (J.S.), Helsinki, Finland.

Correspondence to Dr Pekka Jousilahti, National Public Health Institute, Department of Epidemiology and Health Promotion, Mannerheimintie 166, FIN-00300 Helsinki, Finland. E-mail pekka.jousilahti{at}ktl.fi

Background—The purpose of the present study was to assess the implications of cholesterol distribution and its change on coronary heart disease (CHD) mortality and disease prevention at a population level.

Methods and Results—In five independent risk factor surveys (1972, 1977, 1982, 1987, and 1992) in eastern Finland, serum cholesterol was measured in 27 721 randomly selected men and women aged 30 to 59 years. The association between cholesterol level and CHD risk and the prediction of the effect of different prevention strategies was estimated by use of logistic regression models. The entire cholesterol distribution of the population shifted markedly toward lower levels between 1972 and 1992. The proportion of subjects with a very high cholesterol level (>=8.0 mmol/L), also decreased markedly, from 16% to 3%. The risk of CHD death among subjects with cholesterol >=8.0 mmol/L was {approx}5-fold that of those individuals having cholesterol <5.0 mmol/L. Nevertheless, because CHD risk increases continuously as serum cholesterol increases, and because the number of people having only slightly or moderately increased serum cholesterol was large, most CHD deaths occurred among them. A 10% reduction in cholesterol levels in the entire population would subsequently reduce CHD mortality by 20%, as much as an effective treatment as a 25% decrease in serum cholesterol among all subjects with cholesterol >6.5 mmol/L and four times more than similar treatment of all subjects with cholesterol >=8.0 mmol/L.

Conclusions—The community-based population strategy in cardiovascular disease prevention was effective in decreasing cholesterol levels among the entire population, including the subjects with the highest cholesterol values. The balanced application of both high-risk and population strategies is needed for the effective prevention of CHD.


Key Words: cholesterol • coronary disease • mortality • prevention




This article has been cited by other articles:


Home page
Eur Heart JHome page
N. C. Barengo, S. Katoh, V. Moltchanov, N. Tajima, and J. Tuomilehto
The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study
Eur. Heart J., August 1, 2008; 29(15): 1889 - 1895.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
A. Palikhe, M.-L. Lokki, P. Saikku, M. Leinonen, M. Paldanius, M. Seppanen, V. Valtonen, M. S. Nieminen, and J. Sinisalo
Association of Chlamydia pneumoniae Infection with HLA-B*35 in Patients with Coronary Artery Disease
Clin. Vaccine Immunol., January 1, 2008; 15(1): 55 - 59.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Hozawa, A. R. Folsom, A. R. Sharrett, and L. E. Chambless
Absolute and Attributable Risks of Cardiovascular Disease Incidence in Relation to Optimal and Borderline Risk Factors: Comparison of African American With White Subjects--Atherosclerosis Risk in Communities Study
Arch Intern Med, March 26, 2007; 167(6): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
K.-T. Wang, C.-Y. Chen, C. J.-Y. Hou, C.-H. Tsai, and H.-I Yeh
Comparison of Clinical Characteristics of Acute Myocardial Infarction in Aborigines and Nonaborigines in Taitung Area of Taiwan
Angiology, February 1, 2007; 58(1): 61 - 66.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
D.-H. Lee, M.-H. Ha, S. Kam, B. Chun, J. Lee, K. Song, Y. Boo, L. Steffen, and D. R. Jacobs Jr.
A Strong Secular Trend in Serum Gamma-Glutamyltransferase from 1996 to 2003 among South Korean Men
Am. J. Epidemiol., January 1, 2006; 163(1): 57 - 65.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. S. Vasan, L. M. Sullivan, P. W.F. Wilson, C. T. Sempos, J. Sundstrom, W. B. Kannel, D. Levy, and R. B. D'Agostino
Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors
Ann Intern Med, March 15, 2005; 142(6): 393 - 402.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
H. Tolonen, U. Keil, M. Ferrario, A. Evans, and for the WHO MONICA Project
Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project
Int. J. Epidemiol., February 1, 2005; 34(1): 181 - 192.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Vartiainen
A lot more can be done to prevent cardiovascular diseases
Eur. Heart J., March 2, 2004; 25(6): 457 - 458.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. Corti, V. Fuster, and J.J. Badimon
Strategy for ensuring a better future for the vessel wall
Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A31 - A41.
[Abstract] [PDF]


Home page
HEALTH PROMOT INTHome page
G. Hu, H. Pekkarinen, P. Halonen, O. Hanninen, H. Tian, Z. Guo, and E. Kumpusalo
Different worlds, different tasks for health promotion: comparisons of health risk profiles in Chinese and Finnish rural people
Health Promot. Int., December 1, 2001; 16(4): 315 - 320.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
S Houterman, W. Verschuren, C. Oomen, C. Boersma-Cobbaert, and D Kromhout
Trends in total and high density lipoprotein cholesterol and their determinants in The Netherlands between 1993 and 1997
Int. J. Epidemiol., October 1, 2001; 30(5): 1063 - 1070.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Amarenco
Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction
Neurology, September 1, 2001; 57(90002): S35 - 44.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
A Rosengren, A Dotevall, H Eriksson, and L Wilhelmsen
Optimal risk factors in the population: prognosis, prevalence, and secular trends. Data from Goteborg population studies
Eur. Heart J., January 2, 2001; 22(2): 136 - 144.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
H. J. C. Swan
The Framingham offspring study: A commentary
J. Am. Coll. Cardiol., April 1, 2000; 35(5_Suppl_B): 13B - 17B.
[PDF]


Home page
BMJHome page
T. Marshall, E. Kennedy, and S. Offutt
Exploring a fiscal food policy: the case of diet and ischaemic heart disease • Commentary: Alternative nutrition outcomes using a fiscal food policy
BMJ, January 29, 2000; 320(7230): 301 - 305.
[Full Text]


Home page
J Am Coll CardiolHome page
H. J. C. Swan
The Framingham Offspring Study: a commentary
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1136 - 1140.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster
Epidemic of Cardiovascular Disease and Stroke: The Three Main Challenges : Presented at the 71st Scientific Sessions of the American Heart AssociationDallas, Texas
Circulation, March 9, 1999; 99(9): 1132 - 1137.
[Full Text] [PDF]


Home page
CirculationHome page
P. Jousilahti, E. Vartiainen, J. Tuomilehto, and P. Puska
Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease : A Prospective Follow-Up Study of 14 786 Middle-Aged Men and Women in Finland
Circulation, March 9, 1999; 99(9): 1165 - 1172.
[Abstract] [Full Text] [PDF]